Literature DB >> 17904320

Otoacoustic emissions, ear fullness and tinnitus in the recovery course of sudden deafness.

Ieda M Ishida1, Makoto Sugiura, Masaaki Teranishi, Naomi Katayama, Tsutomu Nakashima.   

Abstract

OBJECTIVE: This study aimed to investigate how the symptoms of ear fullness, tinnitus and otoacoustic emissions (OAE) change in relation to the recovery course of pure tone audiometry thresholds (PTA) in sudden deafness (SD).
METHODS: This study analyzed follow-up data on ear fullness, tinnitus and otoacoustic emissions of eight SD patients with good hearing improvement (Group A) and eight SD patients with poor hearing improvement (Group B) in an attempt to elucidate the behavior of these symptoms in their recovery course. This study was done until there was no change in the PTA for more than 1 week and hearing recovery was no longer expected.
RESULTS: All patients from both groups had ear fullness and tinnitus in association with the onset of SD. However, these symptoms improved only in Group A. showing a significant relationship between PTA recovery and the improvement of ear fullness annoyance (P<0.05), presence of tinnitus (P<0.01), improvement in tinnitus loudness (P<0.01) and in tinnitus annoyance (P<0.01). No patients (Group A or B) had OAE responses at their first examination. In Group A, OAE responses appeared simultaneously with improvement of hearing levels in five patients (63%) and it appeared later than hearing levels improvement in the other three patients (37%) from Group A. No patient from Group B showed OAE response on follow-up.
CONCLUSION: SD patients with good hearing improvement (Group A) tended to have OAE responses and the sensations of the ear fullness and tinnitus improved almost simultaneously with hearing level improvement. Their PTA improvement occurred primarily in the low to mid frequencies, with high frequencies showing less recovery. When hearing recovery was not full, OAEs did not reappear for these frequencies. Patients with poor hearing improvement tended to have absent OAEs and persistent ear fullness and tinnitus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17904320     DOI: 10.1016/j.anl.2007.04.003

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  6 in total

1.  Prediction model for hearing outcome in patients with idiopathic sudden sensorineural hearing loss.

Authors:  Hideaki Suzuki; Takanori Mori; Koichi Hashida; Minori Shibata; Khac-Hung Nguyen; Tetsuro Wakasugi; Nobusuke Hohchi
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-03       Impact factor: 2.503

2.  Uni- and multivariate models for investigating potential prognostic factors in idiopathic sudden sensorineural hearing loss.

Authors:  Marco Lionello; Claudia Staffieri; Stefano Breda; Chiara Turato; Luciano Giacomelli; Paola Magnavita; Cosimo de Filippis; Alberto Staffieri; Gino Marioni
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-25       Impact factor: 2.503

3.  Otoacoustic emissions value in patients with idiopathic sudden sensorineural hearing loss.

Authors:  Aya El-Sayed El-Sayed Gaafar; Elshahat Ibrahem Ismail; Hesham Saad Zaghloul
Journal:  J Otol       Date:  2022-06-23

4.  Curing tinnitus with a Cochlear Implant in a patient with unilateral sudden deafness: a case report.

Authors:  Tobias Kleinjung; Thomas Steffens; Juergen Strutz; Berthold Langguth
Journal:  Cases J       Date:  2009-05-18

5.  Characteristics and Spontaneous Recovery of Tinnitus Related to Idiopathic Sudden Sensorineural Hearing Loss.

Authors:  Guido Mühlmeier; David Baguley; Tony Cox; Markus Suckfüll; Thomas Meyer
Journal:  Otol Neurotol       Date:  2016-07       Impact factor: 2.311

6.  Transition from Acute to Chronic Tinnitus: Predictors for the Development of Chronic Distressing Tinnitus.

Authors:  Elisabeth Wallhäusser-Franke; Roberto D'Amelio; Anna Glauner; Wolfgang Delb; Jérôme J Servais; Karl Hörmann; Ines Repik
Journal:  Front Neurol       Date:  2017-11-20       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.